Suvarthi Das Selected Research

Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)

1/2017

TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suvarthi Das Research Topics

Disease

11	Non-alcoholic Fatty Liver Disease 01/2017 - 08/2013
6	Inflammation (Inflammations) 01/2016 - 04/2013
3	Infections 01/2021 - 02/2016
2	Fibrosis (Cirrhosis) 10/2020 - 12/2013
2	Disease Progression 01/2015 - 06/2013
2	Necrosis 08/2013 - 06/2013
2	Obesity 08/2013 - 06/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	COVID-19 01/2020
1	Hyperglycemia 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Coronavirus Infections 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	Endotoxemia 01/2017
1	Bacterial Infections (Bacterial Infection) 02/2016
1	Neoplasms (Cancer) 02/2016
1	Urinary Tract Infections (Urinary Tract Infection) 02/2016
1	Sinusitis 02/2016
1	Febrile Neutropenia 02/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2016
1	Alcoholic Fatty Liver 04/2013

Drug/Important Bio-Agent (IBA)

7	LeptinIBA 01/2016 - 04/2013
4	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2016 - 08/2013
4	bromodichloromethaneIBA 01/2016 - 06/2013
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016 - 02/2015
3	Purinergic Receptors (Receptors, Purine)IBA 01/2016 - 12/2013
2	Nucleic AcidsIBA 10/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2013
2	LipidsIBA 01/2016 - 07/2015
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2016 - 08/2013
2	Peroxynitrous Acid (Peroxynitrite)IBA 07/2015 - 04/2013
2	Purinergic P2X7 ReceptorsIBA 01/2015 - 12/2013
2	AdipokinesIBA 08/2013 - 06/2013
2	Free RadicalsIBA 08/2013 - 06/2013
1	Antiviral Agents (Antivirals)IBA 01/2021
1	VaccinesIBA 01/2021
1	AntigensIBA 10/2020
1	Immunoglobulins (Immunoglobulin)IBA 10/2020
1	AntibodiesIBA 10/2020
1	NADP (NADPH)IBA 10/2020
1	Oxidoreductases (Dehydrogenase)IBA 10/2020
1	EnzymesIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	SolutionsIBA 01/2020
1	Advanced Glycation End ProductsIBA 01/2020
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017
1	Toll-Like Receptor 4IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2016
1	amsonic acid (DAS)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Fas Ligand Protein (Fas Ligand)IBA 01/2016
1	sparstolonin BIBA 01/2016
1	benzeneboronic acidIBA 07/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015
1	MicroRNAs (MicroRNA)IBA 02/2015
1	2,2'- (hydroxynitrosohydrazono)bis- ethanamineIBA 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015
1	Nitric Oxide DonorsIBA 01/2015
1	Methionine (L-Methionine)FDA Link 01/2015
1	CytokinesIBA 01/2015
1	Choline (Choline Chloride)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 08/2013
1	Drinking WaterIBA 08/2013
1	CollagenIBA 08/2013
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013
1	3-nitrotyrosineIBA 06/2013